# A Study of the Safety, Tolerability, Pharmacokinetics and Food Effect After Single and Multiple Ascending Oral Doses

> **NCT05218434** · PHASE1 · COMPLETED · sponsor: **Artax Biopharma Inc** · enrollment: 64 (actual)

## Conditions studied

- Autoimmune Diseases

## Interventions

- **DRUG:** AX-158

## Key facts

- **NCT ID:** NCT05218434
- **Lead sponsor:** Artax Biopharma Inc
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2021-11-17
- **Primary completion:** 2022-11-16
- **Final completion:** 2022-12-03
- **Target enrollment:** 64 (ACTUAL)
- **Last updated:** 2024-08-23

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05218434

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05218434, "A Study of the Safety, Tolerability, Pharmacokinetics and Food Effect After Single and Multiple Ascending Oral Doses". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT05218434. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*